Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | DVL1 |
| Upstream (Parents) |
|---|
| (<<) CAT → DVL1 |
| (<<) DAB2 → DVL1 |
| (<<) GLTPD1 → DVL1 |
| (<<) HSPA14 → DVL1 |
| (<<) ITGB1 → DVL1 |
| (<<) MAP3K2 → DVL1 |
| (<<) MAP6D1 → DVL1 |
| (<<) PINX1 → DVL1 |
| (<<) RRP1 → DVL1 |
| (<<) TCOF1 → DVL1 |
| (<<) TIMM13 → DVL1 |
| (<<) TPM1 → DVL1 |
| (<<) TPM3 → DVL1 |
| (<<) TXNIP → DVL1 |
| Downstream (Children) |
|---|
| DVL1 → ATAD3C (>>) |
| DVL1 → BCAR1 (>>) |
| DVL1 → BZW2 (>>) |
| DVL1 → CARD9 (>>) |
| DVL1 → CASP9 (>>) |
| DVL1 → CHI3L1 (>>) |
| DVL1 → FAM131C (>>) |
| DVL1 → FAS (>>) |
| DVL1 → FCRLB (>>) |
| DVL1 → FZD5 (>>) |
| DVL1 → LOC100131262 (>>) |
| DVL1 → LRP8 (>>) |
| DVL1 → LYPLA2 (>>) |
| DVL1 → MAP3K6 (>>) |
| DVL1 → OVOL1 (>>) |
| DVL1 → PABPC3 (>>) |
| DVL1 → PRKCZ (>>) |
| DVL1 → PRR7 (>>) |
| DVL1 → PTGS1 (>>) |
| DVL1 → PTK2 (>>) |
| DVL1 → RASSF1 (>>) |
| DVL1 → RCOR2 (>>) |
| DVL1 → RPS6KA1 (>>) |
| DVL1 → SEMA3A (>>) |
| DVL1 → TUBA1A (>>) |
